RNASET2 and nonpapillary renal cell carcinoma: After exposure to different concentrations of PT2385 for 24 h, RNASET2 transcription was detected and the results showed that treatment with 0.1 μm PT2385 significantly decreased its expression in ccRCC cells (Fig. 5G).